Luis Felipe Jave-Suarez
Overview
Explore the profile of Luis Felipe Jave-Suarez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
485
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Avalos-Navarro G, Bautista-Herrera L, Garibaldi-Rios A, Ramirez-Patino R, Gutierrez-Garcia M, Briseno-Alvarez P, et al.
Diseases
. 2025 Jan;
13(1).
PMID: 39851465
Background/objectives: Breast cancer (BC) is a heterogeneous disease with multifactorial origins, including environmental, genetic, and immunological factors. Inflammatory cytokines, such as alpha 1 antitrypsin (α1-AT), are increased in BC and...
2.
Lara-Navarro I, Jave-Suarez L, Marchal J, Jaloma-Cruz A
Life (Basel)
. 2025 Jan;
14(12.
PMID: 39768347
Hemophilia B is a genetic disorder characterized by clotting factor IX deficiency and bleeding in joints and muscles. Current treatments involve intravenous infusion of plasma-derived products or recombinant proteins, which...
3.
Rodriguez-Sanabria J, Rosas-Campos R, Vazquez-Esqueda A, Palacios-Marin I, Jimenez-Chillaron J, Escutia-Gutierrez R, et al.
Sci Rep
. 2024 Oct;
14(1):24714.
PMID: 39433954
NASH is characterized by hepatic lipid accumulation and inflammation; and JMJD2B-a histone demethylase-upregulation has been linked to its progression. Pirfenidone (PFD) is an antifibrotic agent with anti-inflammatory and antioxidant effects...
4.
Gaxiola-Rubio A, Jave-Suarez L, Hernandez-Silva C, Ramirez-de-Arellano A, Villegas-Pineda J, Lizarraga-Ledesma M, et al.
Cancers (Basel)
. 2024 Oct;
16(19).
PMID: 39409923
Background/objectives: Estrogens and HPV are necessary for cervical cancer (CC) development. The levels of the G protein-coupled estrogen receptor (GPER) increase as CC progresses, and HPV oncoproteins promote GPER expression....
5.
Carranza-Aranda A, Jave-Suarez L, Flores-Hernandez F, Huizar-Lopez M, Herrera-Rodriguez S, Santerre A
Mol Med Rep
. 2024 Oct;
30(6).
PMID: 39392050
Acute myeloid leukemia (AML) is the most common hematological cancer in the adult population worldwide. Approximately 35% of patients with AML present internal tandem duplication (ITD) mutations in the FMS‑like...
6.
Renteria-Flores F, Garcia-Chagollan M, Jave-Suarez L
Vaccines (Basel)
. 2024 Sep;
12(9).
PMID: 39340000
From the first report in 1891 by Dr. Coley of the effective treatment of tumors in 1000 patients with Streptococcus and the first successful use of bacterial vectors for transferring...
7.
Pina-Cruz R, Molina-Pineda A, Aguila-Estrada M, Villasenor-Garcia M, Hernandez-Flores G, Jave-Suarez L, et al.
Anticancer Agents Med Chem
. 2024 Sep;
24(20):1483-1500.
PMID: 39229997
Aims: This study aimed to assess the effects of AEO in an model of cell lines derived from cervical cancer-namely, HeLa and SiHa-by screening for AEO's cytotoxic properties and examining...
8.
Rosas-Campos R, Sandoval-Rodriguez A, Rodriguez-Sanabria J, Vazquez-Esqueda A, Alfaro-Martinez C, Escutia-Gutierrez R, et al.
Antioxidants (Basel)
. 2024 Jun;
13(6).
PMID: 38929103
Microbial community control is crucial for maintaining homeostasis of the gut-liver axis in metabolic dysfunction-associated steatotic liver disease (MASLD). Here, we show that supplementation with a mixture of Mexican foodstuffs...
9.
Bueno-Urquiza L, Godinez-Rubi M, Villegas-Pineda J, Vega-Magana A, Jave-Suarez L, Puebla-Mora A, et al.
Cells
. 2024 Apr;
13(7.
PMID: 38606999
Cervical cancer (CC) is the fourth leading cancer among women and is one of the principal gynecological malignancies. In the tumor microenvironment, cancer-associated fibroblasts (CAFs) play a crucial role during...
10.
Del Refugio Ruiz-Barrios L, Pineda-Razo T, Hernandez-Flores G, Ortiz-Lazareno P, Bravo-Cuellar A, Macias-Lamas A, et al.
Biomed Rep
. 2024 Feb;
20(3):38.
PMID: 38343658
Ductal adenocarcinoma represents 90-95% of pancreatic cancer (PC) cases and it is an aggressive disease with asymptomatic evolution at early stages, non-specific symptoms and a typical late diagnosis with a...